{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:57:40Z","timestamp":1793170660738,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12887-016-0771-y","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T12:01:13Z","timestamp":1484308873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean"],"prefix":"10.1186","volume":"17","author":[{"given":"Ra\u00fal F.","family":"Vel\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre C.","family":"Linhares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Seron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Lorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ortega-Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"771_CR1","unstructured":"World Health Organization. Diarrhoeal disease. http:\/\/www.who.int\/mediacentre\/factsheets\/fs330\/en\/ . Accessed 7 Dec 2016."},{"key":"771_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, GEMS): a prospective, case\u2013control study. Lancet. 2013;382:209\u201322.","journal-title":"Lancet"},{"key":"771_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","volume":"12","author":"JE Tate","year":"2012","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5\u00a0years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136\u201341.","journal-title":"Lancet Infect Dis"},{"key":"771_CR4","unstructured":"World Health Organization Position Paper. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82(32):285\u201395. http:\/\/www.who.int\/wer\/2007\/wer8232\/en\/ . Accessed 7 Dec 2016."},{"key":"771_CR5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","volume":"335","author":"FR Vel\u00e1zquez","year":"1996","unstructured":"Vel\u00e1zquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022\u20138.","journal-title":"N Engl J Med"},{"issue":"7","key":"771_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1473-3099(12)70029-4","volume":"12","author":"MM Patel","year":"2012","unstructured":"Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis. 2012;12(7):561\u201370.","journal-title":"Lancet Infect Dis"},{"key":"771_CR7","first-page":"7","volume":"97","author":"MB Rennels","year":"1996","unstructured":"Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the national multicenter trial. United states rotavirus vaccine efficacy group. Pediatrics. 1996;97:7\u201313.","journal-title":"Pediatrics"},{"key":"771_CR8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(97)05118-0","volume":"350","author":"J Joensuu","year":"1997","unstructured":"Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350:1205\u20139.","journal-title":"Lancet"},{"key":"771_CR9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199710233371701","volume":"337","author":"I P\u00e9rez-Schael","year":"1997","unstructured":"P\u00e9rez-Schael I, Gunti\u00f1as MJ, P\u00e9rez M, Pagone V, Rojas AM, Gonz\u00e1lez R, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337:1181\u20137.","journal-title":"N Engl J Med"},{"key":"771_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","volume":"20","author":"P Kramarz","year":"2001","unstructured":"Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20:410\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","volume":"344","author":"TV Murphy","year":"2001","unstructured":"Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564\u201372.","journal-title":"N Engl J Med"},{"key":"771_CR12","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1542\/peds.110.6.e67","volume":"110","author":"G Peter","year":"2002","unstructured":"Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110:e67.","journal-title":"Pediatrics"},{"key":"771_CR13","unstructured":"PATH. Country introductions of rotavirus vaccines. Available at: http:\/\/www.path.org\/vaccineresources\/details.php?i=2235 . Accessed 6 Jan 2017."},{"key":"771_CR14","unstructured":"De Oliveira LH, Sanwogou J, Ruiz-Matus C, Tambini G, Wang SA, Agocs M, et al. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006\u20132010. MMWR Morb Mortal Wkly Rep. 2011;60:1611\u20134. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6047a2.htm?s_cid\u2009=\u2009mm6047a2_w . Accessed 7 Dec 2016."},{"issue":"2","key":"771_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/rmv.682","volume":"21","author":"AC Linhares","year":"2011","unstructured":"Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, et al. Burden and typing of rotavirus group a in Latin America and the Caribbean: systematic review and meta-analysis. Rev Med Virol. 2011;21(2):89\u2013109.","journal-title":"Rev Med Virol"},{"key":"771_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","volume":"354","author":"T Vesikari","year":"2006","unstructured":"Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23\u201333.","journal-title":"N Engl J Med"},{"key":"771_CR17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.inf.0000178294.13954.a1","volume":"24","author":"B Salinas","year":"2005","unstructured":"Salinas B, P\u00e9rez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarz\u00e1bal JP, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24:807\u201316.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","volume":"354","author":"GM Ruiz-Palacios","year":"2006","unstructured":"Ruiz-Palacios GM, P\u00e9rez-Schael I, Vel\u00e1zquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11\u201322.","journal-title":"N Engl J Med"},{"key":"771_CR19","unstructured":"World Health Organization Position Paper. Rotavirus vaccines. Wkly Epidemiol Rec. 2013;88(5):49\u201364. http:\/\/www.who.int\/wer\/2013\/wer8805\/en\/ . Accessed 7 Dec 2016."},{"issue":"Suppl","key":"771_CR20","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/605025","volume":"200","author":"UD Parashar","year":"2009","unstructured":"Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200(Suppl):S9\u2013S15.","journal-title":"J Infect Dis"},{"key":"771_CR21","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"771_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/00365549009027046","volume":"22","author":"T Ruuska","year":"1990","unstructured":"Ruuska T, Vesikari T. Rotavirus disease in Finnish children : use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22:259\u201367.","journal-title":"Scand J Infect Dis"},{"key":"771_CR23","unstructured":"Lewis K. Vesikari clinical severity scoring system manual. 2011. https:\/\/www.path.org\/publications\/files\/VAD_vesikari_scoring_manual.pdf . Accessed 7 Dec 2016."},{"key":"771_CR24","unstructured":"The Cochrane Collaboration tool for assessing risk of bias. http:\/\/handbook.cochrane.org\/chapter_8\/8_assessing_risk_of_bias_in_included_studies.htm . Accessed 7 Dec 2016."},{"key":"771_CR25","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"771_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"issue":"Suppl 2","key":"771_CR27","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1201-9712(07)60019-8","volume":"11","author":"T Vesikari","year":"2007","unstructured":"Vesikari T, Itzler R, Matson DO, Santosham M, Christie CDC, Coia M, et al. Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis. 2007;11 Suppl 2:S29\u201335.","journal-title":"Int J Infect Dis"},{"key":"771_CR28","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1542\/peds.2010-1240","volume":"126","author":"CDC Christie","year":"2010","unstructured":"Christie CDC, Duncan ND, Thame KA, Onorato MT, Smith HD, Malcolm LG, et al. Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization. Pediatrics. 2010;126:e1499\u2013506.","journal-title":"Pediatrics"},{"key":"771_CR29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/vim.2006.0105","volume":"20","author":"OL Rojas","year":"2007","unstructured":"Rojas OL, Caicedo L, Guzm\u00e1n C, Rodr\u00edguez L-S, Casta\u00f1eda J, Uribe L, et al. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine. Viral Immunol. 2007;20:300\u201311.","journal-title":"Viral Immunol"},{"key":"771_CR30","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","volume":"30","author":"MW Tregnaghi","year":"2011","unstructured":"Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, et al. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J. 2011;30:e103\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR31","first-page":"217","volume":"83","author":"EC Araujo","year":"2007","unstructured":"Araujo EC, Clemens SAC, Oliveira CS, Justino MCA, Rubio P, Gabbay YB, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy Brazilian infants. J Pediatr (Rio J). 2007;83:217\u201324.","journal-title":"J Pediatr (Rio J)"},{"key":"771_CR32","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1542\/peds.2006-2630","volume":"120","author":"GM Ruiz-Palacios","year":"2007","unstructured":"Ruiz-Palacios GM, Guerrero ML, Bautista-M\u00e1rquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-Gonz\u00e1lez L, et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics. 2007;120:e253\u201361.","journal-title":"Pediatrics"},{"key":"771_CR33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(08)60524-3","volume":"371","author":"AC Linhares","year":"2008","unstructured":"Linhares AC, Vel\u00e1zquez FR, P\u00e9rez-Schael I, S\u00e1ez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2\u00a0years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181\u20139.","journal-title":"Lancet"},{"key":"771_CR34","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","volume":"301","author":"M Patel","year":"2009","unstructured":"Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301:2243\u201351.","journal-title":"JAMA"},{"issue":"3","key":"771_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/649843","volume":"201","author":"JB Correia","year":"2010","unstructured":"Correia JB, Patel MM, Nakagomi O, Montenegro FMU, Germano EM, Correia NB, et al. Effectiveness of monovalent rotavirus vaccine (RotarixTM) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201(3):363\u20139.","journal-title":"J Infect Dis"},{"key":"771_CR36","doi-asserted-by":"crossref","first-page":"c2825","DOI":"10.1136\/bmj.c2825","volume":"340","author":"O Palma De","year":"2010","unstructured":"De Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case\u2013control study. BMJ. 2010;340:c2825.","journal-title":"BMJ"},{"key":"771_CR37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/INF.0b013e3182055cc2","volume":"30","author":"MCA Justino","year":"2011","unstructured":"Justino MCA, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JDP, Abreu E, et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Bel\u00e9m, Brazil. Pediatr Infect Dis J. 2011;30:396\u2013401.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/INF.0b013e318253add3","volume":"31","author":"FR Vel\u00e1zquez","year":"2012","unstructured":"Vel\u00e1zquez FR, Colindres RE, Grajales C, Hern\u00e1ndez MT, Mercadillo MG, Torres FJ, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J. 2012;31:736\u201344.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","volume":"57","author":"JB Carlin","year":"2013","unstructured":"Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s national immunization program. Clin Infect Dis. 2013;57:1427\u201334.","journal-title":"Clin Infect Dis"},{"key":"771_CR40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","volume":"370","author":"WK Yih","year":"2014","unstructured":"Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370:503\u201312.","journal-title":"N Engl J Med"},{"key":"771_CR41","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","volume":"364","author":"MM Patel","year":"2011","unstructured":"Patel MM, L\u00f3pez-Collada VR, Bulh\u00f5es MM, De Oliveira LH, Bautista M\u00e1rquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364:2283\u201392.","journal-title":"N Engl J Med"},{"key":"771_CR42","first-page":"577","volume":"48","author":"K Ehresman","year":"1999","unstructured":"Ehresman K, Lynfield R, Danila R, Black S, Shinefield H, Fireman B, et al. Intussusception among recipients of rotavirus vaccine-United States, 1998\u20131999. MMWR Morb Mortal Wkly Rep. 1999;48:577\u201381.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"771_CR43","unstructured":"World Health Organization. Acute intussusception in infants and children. http:\/\/vaccine-safety-training.org\/tl_files\/vs\/pdf\/acute-intussusception-infants-children.pdf . Accessed 7 Dec 2016."},{"key":"771_CR44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00103-013-1893-0","volume":"57","author":"D Oberle","year":"2014","unstructured":"Oberle D, Jenke AC, von Kries R, Mentzer D, Keller-Stanislawski B. Rotavirus vaccination: a risk factor for intussusception? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57:234\u201341.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"771_CR45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0b013e318278bb4e","volume":"32","author":"T Vesikari","year":"2013","unstructured":"Vesikari T. Intussusception after human rotavirus vaccine. Pediatr Infect Dis J. 2013;32:579\u201380.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR46","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/cid\/cis191","volume":"54","author":"R Desai","year":"2012","unstructured":"Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CFB, et al. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clin Infect Dis. 2012;54:1397\u2013405.","journal-title":"Clin Infect Dis"},{"key":"771_CR47","unstructured":"PAHO WHO. Countries using rotavirus and pneumococcal vaccine. 2016. http:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=2586%3A2010-countries-using-rotavirus-pneumococcal-vaccine&catid=1552%3Anew-vaccines-about&Itemid=2087&lang=en . Accessed 7 Dec 2016."},{"key":"771_CR48","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/INF.0b013e3181fefb32","volume":"30","author":"M Quintanar-Solares","year":"2011","unstructured":"Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children\u2009<\u20095\u00a0years of age in Mexico. Pediatr Infect Dis J. 2011;30:S11\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR49","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1542\/peds.2011-3478","volume":"130","author":"M Patel","year":"2012","unstructured":"Patel M, Pedreira C, De Oliveira LH, Uma\u00f1a J, Tate J, Lopman B, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics. 2012;130:e365\u201372.","journal-title":"Pediatrics"},{"key":"771_CR50","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4161\/hv.24338","volume":"9","author":"A Cardellino","year":"2013","unstructured":"Cardellino A, Khawaja S, S\u00e1nchez Cruz E, Mast TC. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method. Hum Vaccin Immunother. 2013;9:1449\u201353.","journal-title":"Hum Vaccin Immunother"},{"key":"771_CR51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","volume":"362","author":"V Richardson","year":"2010","unstructured":"Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299\u2013305.","journal-title":"N Engl J Med"},{"key":"771_CR52","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.ijid.2011.09.003","volume":"16","author":"V Bayard","year":"2012","unstructured":"Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barr\u00eda E, et al. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2012;16:e94\u20138.","journal-title":"Int J Infect Dis"},{"key":"771_CR53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.13-0026","volume":"89","author":"S Becker-Dreps","year":"2013","unstructured":"Becker-Dreps S, Mel\u00e9ndez M, Liu L, Zambrana LE, Paniagua M, Weber DJ, et al. Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua. Am J Trop Med Hyg. 2013;89:246\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"771_CR54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1586\/14760584.2014.905747","volume":"13","author":"R Ulloa-Gutierrez","year":"2014","unstructured":"Ulloa-Gutierrez R, Avila-Aguero ML. Rotavirus vaccination in Central American children. Expert Rev Vaccines. 2014;13:687\u201390.","journal-title":"Expert Rev Vaccines"},{"key":"771_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bjid.2013.05.010","volume":"18","author":"A Luchs","year":"2014","unstructured":"Luchs A, Cilli A, Morillo SG. de cassia compagnoli Carmona R, do carmo sampaio Tavares timenetsky M. Rotavirus in adults, brazil, 2004\u20132011: G2P[4] dominance and potential impact on vaccination. Braz J Infect Dis. 2014;18:53\u20139.","journal-title":"Braz J Infect Dis"},{"key":"771_CR56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/hv.19757","volume":"8","author":"S Khawaja","year":"2012","unstructured":"Khawaja S, Cardellino A, Klotz D, Kuter BJ, Feinberg MB, Colatrella BD, et al. Evaluating the health impact of a public-private partnership: to reduce rotavirus disease in Nicaragua. Hum Vaccin Immunother. 2012;8:777\u201382.","journal-title":"Hum Vaccin Immunother"},{"key":"771_CR57","doi-asserted-by":"crossref","first-page":"f3726","DOI":"10.1136\/bmj.f3726","volume":"346","author":"MM Patel","year":"2013","unstructured":"Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case\u2013control study. BMJ. 2013;346:f3726.","journal-title":"BMJ"},{"key":"771_CR58","first-page":"2740","volume":"32","author":"MYT Ichihara","year":"2014","unstructured":"Ichihara MYT, Rodrigues LC, Teles Santos CAS, Teixeira M da GLC, De Jesus SR, Alvim De Matos SM, et al. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: a case\u2013control study. Vaccine. 2014;32:2740\u20137.","journal-title":"Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: a case\u2013control study. Vaccine."},{"key":"771_CR59","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2012-3804","volume":"132","author":"MM Cortese","year":"2013","unstructured":"Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013;132:e25\u201333.","journal-title":"Pediatrics"},{"key":"771_CR60","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/INF.0000000000000086","volume":"32","author":"T Vesikari","year":"2013","unstructured":"Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, et al. Impact and effectiveness of RotaTeq\u00ae vaccine based on 3\u00a0years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013;32:1365\u201373.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR61","first-page":"CD008521","volume":"11","author":"K Soares-Weiser","year":"2012","unstructured":"Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;11:CD008521.","journal-title":"Cochrane Database Syst Rev"},{"key":"771_CR62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","volume":"376","author":"GE Armah","year":"2010","unstructured":"Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606\u201314.","journal-title":"Lancet"},{"key":"771_CR63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289\u201398.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"771_CR64","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2011.08.124","volume":"30","author":"RF Breiman","year":"2012","unstructured":"Breiman RF, Zaman K, Armah G, Sow SO, Anh DD, Victor JC, et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 2012;30 Suppl 1:A24\u20139.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"771_CR65","doi-asserted-by":"crossref","first-page":"A71","DOI":"10.1016\/j.vaccine.2011.11.094","volume":"30","author":"SO Sow","year":"2012","unstructured":"Sow SO, Tapia M, Haidara FC, Ciarlet M, Diallo F, Kodio M, et al. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Vaccine. 2012;30 Suppl 1:A71\u20138.","journal-title":"Vaccine"},{"key":"771_CR66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-3024.2008.01069.x","volume":"31","author":"G Malafaia","year":"2009","unstructured":"Malafaia G, Serafim TD, Silva ME, Pedrosa ML, Rezende SA. Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB\/c mice. Parasite Immunol. 2009;31:41\u20139.","journal-title":"Parasite Immunol"},{"key":"771_CR67","doi-asserted-by":"crossref","first-page":"e73461","DOI":"10.1371\/journal.pone.0073461","volume":"8","author":"N Zhao","year":"2013","unstructured":"Zhao N, Wang X, Zhang Y, Gu Q, Huang F, Zheng W, et al. Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice. PLoS One. 2013;8:e73461.","journal-title":"PLoS One"},{"key":"771_CR68","doi-asserted-by":"crossref","first-page":"e41720","DOI":"10.1371\/journal.pone.0041720","volume":"7","author":"BA Lopman","year":"2012","unstructured":"Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One. 2012;7:e41720.","journal-title":"PLoS One"},{"key":"771_CR69","doi-asserted-by":"crossref","first-page":"e82966","DOI":"10.1371\/journal.pone.0082966","volume":"8","author":"KS Chattha","year":"2013","unstructured":"Chattha KS, Kandasamy S, Vlasova AN, Saif LJ. Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model. PLoS One. 2013;8:e82966.","journal-title":"PLoS One"},{"key":"771_CR70","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.1203575","volume":"190","author":"AN Vlasova","year":"2013","unstructured":"Vlasova AN, Chattha KS, Kandasamy S, Siegismund CS, Saif LJ. Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model. J Immunol. 2013;190:4742\u201353.","journal-title":"J Immunol"},{"key":"771_CR71","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4161\/hv.24958","volume":"9","author":"B Jiang","year":"2013","unstructured":"Jiang B, Wang Y, Glass RI. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? evidence from animal studies. Hum Vaccin Immunother. 2013;9:1634\u20137.","journal-title":"Hum Vaccin Immunother"},{"key":"771_CR72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","volume":"14","author":"E Leshem","year":"2014","unstructured":"Leshem E, Lopman B, Glass R, Gentsch J, B\u00e1nyai K, Parashar U, Patel M. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:847\u201356.","journal-title":"Lancet Infect Dis"},{"key":"771_CR73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/cit164","volume":"57","author":"DC Payne","year":"2013","unstructured":"Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5\u00a0years of age, 2009\u20132011. Clin Infect Dis. 2013;57:13\u201320.","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"771_CR74","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1086\/653555","volume":"202","author":"S Todd","year":"2010","unstructured":"Todd S, Page NA, Duncan Steele A, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: review of studies published during 1997\u20132006. J Infect Dis. 2010;202(Suppl):S34\u201342.","journal-title":"J Infect Dis"},{"key":"771_CR75","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/INF.0000000000000105","volume":"33","author":"W-C Chang","year":"2014","unstructured":"Chang W-C, Yen C, Wu F-T, Huang Y-C, Lin J-S, Huang F-C, et al. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. Pediatr Infect Dis J. 2014;33:e81\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"771_CR76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S1020-49892007000300003","volume":"21","author":"RD Rheingans","year":"2007","unstructured":"Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica. 2007;21:205\u201316.","journal-title":"Rev Panam Salud Publica"},{"key":"771_CR77","doi-asserted-by":"crossref","first-page":"e47511","DOI":"10.1371\/journal.pone.0047511","volume":"7","author":"AJ Hoek Van","year":"2012","unstructured":"Van Hoek AJ, Ngama M, Ismail A, Chuma J, Cheburet S, Mutonga D, Kamau T, Nokes DJ. A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between rotarix and RotaTeq vaccines. PLoS One. 2012;7:e47511.","journal-title":"PLoS One"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-016-0771-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T14:14:42Z","timestamp":1568729682000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-016-0771-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/s12887-016-0771-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"14"}}